Cargando…

Optimizing prediction of response to antidepressant medications using machine learning and environmental data

INTRODUCTION: Major depressive disorder (MDD) is complex and multifactorial, posing a major challenge of tailoring the optimal medication for each patient. Current practice for MDD treatment mainly relies on trial-and-error, with estimated 42%-53% response rates for antidepressant use. OBJECTIVES: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Spinrad, A., Darki-Morag, S., Taliaz, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480190/
http://dx.doi.org/10.1192/j.eurpsy.2021.2000
_version_ 1784790995354779648
author Spinrad, A.
Darki-Morag, S.
Taliaz, D.
author_facet Spinrad, A.
Darki-Morag, S.
Taliaz, D.
author_sort Spinrad, A.
collection PubMed
description INTRODUCTION: Major depressive disorder (MDD) is complex and multifactorial, posing a major challenge of tailoring the optimal medication for each patient. Current practice for MDD treatment mainly relies on trial-and-error, with estimated 42%-53% response rates for antidepressant use. OBJECTIVES: We sought to generate an accurate predictor of response to a panel of antidepressants and optimize treatment selection using a data-driven approach analyzing combinations of clinical and demographic factors. METHODS: We analyzed the response patterns of patients to five antidepressant medications in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study and the Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS), and employed state-of-the-art machine learning (ML) tools to generate a predictive algorithm. To validate our results and confirm the algorithm’s external generalizability outside of its training groups, we assessed its capacity to predict individualized antidepressant responses on a separate validation and test sets consisting of 1,021 patients overall from both studies. RESULTS: The algorithm’s ML prediction models achieved an average accuracy of 0.6416 (64.16%, SD 4.4) across the analyzed medications, and a cumulative accuracy of 0.6012 (60.12%), AUC of 0.601, sensitivity of 0.6034 (60.34%) and specificity of 0.599 (59.9%). CONCLUSIONS: These findings support applying ML to accumulating data derived from large studies to achieve a much-needed improvement in the treatment of depression. By an immediate analysis of large amount of combinatorial data at the point of care, such prediction models may support doctors’ prescription decisions, potentially allowing them to tailor the right antidepressant medication sooner. DISCLOSURE: Dekel Taliaz is the founder and CEO of Taliaz and reports stock ownership in Taliaz. Amit Spinrad and Sne Darki-Morag serve as data scientists in Taliaz.
format Online
Article
Text
id pubmed-9480190
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94801902022-09-29 Optimizing prediction of response to antidepressant medications using machine learning and environmental data Spinrad, A. Darki-Morag, S. Taliaz, D. Eur Psychiatry Abstract INTRODUCTION: Major depressive disorder (MDD) is complex and multifactorial, posing a major challenge of tailoring the optimal medication for each patient. Current practice for MDD treatment mainly relies on trial-and-error, with estimated 42%-53% response rates for antidepressant use. OBJECTIVES: We sought to generate an accurate predictor of response to a panel of antidepressants and optimize treatment selection using a data-driven approach analyzing combinations of clinical and demographic factors. METHODS: We analyzed the response patterns of patients to five antidepressant medications in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study and the Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS), and employed state-of-the-art machine learning (ML) tools to generate a predictive algorithm. To validate our results and confirm the algorithm’s external generalizability outside of its training groups, we assessed its capacity to predict individualized antidepressant responses on a separate validation and test sets consisting of 1,021 patients overall from both studies. RESULTS: The algorithm’s ML prediction models achieved an average accuracy of 0.6416 (64.16%, SD 4.4) across the analyzed medications, and a cumulative accuracy of 0.6012 (60.12%), AUC of 0.601, sensitivity of 0.6034 (60.34%) and specificity of 0.599 (59.9%). CONCLUSIONS: These findings support applying ML to accumulating data derived from large studies to achieve a much-needed improvement in the treatment of depression. By an immediate analysis of large amount of combinatorial data at the point of care, such prediction models may support doctors’ prescription decisions, potentially allowing them to tailor the right antidepressant medication sooner. DISCLOSURE: Dekel Taliaz is the founder and CEO of Taliaz and reports stock ownership in Taliaz. Amit Spinrad and Sne Darki-Morag serve as data scientists in Taliaz. Cambridge University Press 2021-08-13 /pmc/articles/PMC9480190/ http://dx.doi.org/10.1192/j.eurpsy.2021.2000 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Spinrad, A.
Darki-Morag, S.
Taliaz, D.
Optimizing prediction of response to antidepressant medications using machine learning and environmental data
title Optimizing prediction of response to antidepressant medications using machine learning and environmental data
title_full Optimizing prediction of response to antidepressant medications using machine learning and environmental data
title_fullStr Optimizing prediction of response to antidepressant medications using machine learning and environmental data
title_full_unstemmed Optimizing prediction of response to antidepressant medications using machine learning and environmental data
title_short Optimizing prediction of response to antidepressant medications using machine learning and environmental data
title_sort optimizing prediction of response to antidepressant medications using machine learning and environmental data
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480190/
http://dx.doi.org/10.1192/j.eurpsy.2021.2000
work_keys_str_mv AT spinrada optimizingpredictionofresponsetoantidepressantmedicationsusingmachinelearningandenvironmentaldata
AT darkimorags optimizingpredictionofresponsetoantidepressantmedicationsusingmachinelearningandenvironmentaldata
AT taliazd optimizingpredictionofresponsetoantidepressantmedicationsusingmachinelearningandenvironmentaldata